Wire Stories
Dr. Reddy’s Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS� (favipiravir) Tablets for the Treatment of COVID-19 under Health Canada�s Interim Order
HYDERABAD, India & MISSISSAUGA, Ontario & HALIFAX, Nova Scotia–(BUSINESS WIRE)–Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its...